Romain Appay

6PUBLICATIONS
42CO-AUTHORS
Cancer diagnosisMolecular targetsMedical molecular engineering of nucleic acids and proteinsGene expression (incl. microarray and other genome-wide approaches)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 13, 2026
Droplet Digital PCR Assessment of MDM2 Amplification in Liposarcoma Diagnosis and Prognosis: A French Single-Center Cohort Study.

|Oct 16, 2025
Correction: Tabouret et al. TP5, a Peptide Inhibitor of Aberrant and Hyperactive CDK5/p25: A Novel Therapeutic Approach against Glioblastoma. Cancers 2020, 12, 1935.

Emeline Tabouret, Herui Wang, Niranjana Amin

|Feb 19, 2025
Vanishing Contrast Enhancement of a Diffuse Midline Glioma.

Charles Champeaux Depond, Philippe Metellus, Emmanuel Gross

|Apr 17, 2024
A Cohort Study of CNS Tumors in Multiple Endocrine Neoplasia Type 1.

Thomas Graillon, Pauline Romanet, Clara Camilla

|Feb 11, 2023
Plasma nanoDSF Denaturation Profile at Baseline Is Predictive of Glioblastoma EGFR Status.

Rémi Eyraud, Stéphane Ayache, Philipp O Tsvetkov

|Sep 09, 2018
Somatostatin receptor 2A protein expression characterizes anaplastic oligodendrogliomas with favorable outcome.

Romain Appay, Emeline Tabouret, Mehdi Touat

Pageof 1

Frequent Collaborators

2 joint publications

Emeline Tabouret

1 joint publications

Rémi Eyraud

1 joint publications

Philipp O Tsvetkov

1 joint publications

François Devred